{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:16:33Z","timestamp":1792995393013,"version":"4.5.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10192-1","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:44:52Z","timestamp":1778327092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"4","key":"10192_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/15548627.2017.1381804","volume":"14","author":"L Jiao","year":"2018","unstructured":"Jiao L, Zhang HL, Li DD, Yang KL, Tang J, Li X, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 2018;14(4):671\u201384.","journal-title":"Autophagy"},{"key":"10192_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010060","author":"G \u00c7etin","year":"2021","unstructured":"\u00c7etin G, Klafack S, Studencka-Turski M, Kr\u00fcger E, Ebstein F. The ubiquitin-proteasome system in immune cells. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11010060.","journal-title":"Biomolecules"},{"issue":"11","key":"10192_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41580-018-0040-z","volume":"19","author":"A Rousseau","year":"2018","unstructured":"Rousseau A, Bertolotti A. Regulation of proteasome assembly and activity in health and disease. Nat Rev Mol Cell Biol. 2018;19(11):697\u2013712.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10192_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/pr.117.015370","volume":"71","author":"TA Thibaudeau","year":"2019","unstructured":"Thibaudeau TA, Smith DM. A practical review of proteasome pharmacology. Pharmacol Rev. 2019;71(2):170\u201397.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10192_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","volume":"24","author":"G Kleiger","year":"2014","unstructured":"Kleiger G, Mayor T. Perilous journey: a tour of the ubiquitin\u2013proteasome system. Trends Cell Biol. 2014;24(6):352\u20139.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"10192_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder NA, Silva GM. Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J Biol Chem. 2021;297(3):101077.","journal-title":"J Biol Chem"},{"issue":"1","key":"10192_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07530-y","volume":"24","author":"L Song","year":"2025","unstructured":"Song L, Kong D, Yang L. Deciphering USP8\u2019s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas. J Transl Med. 2025;24(1):36.","journal-title":"J Transl Med"},{"key":"10192_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111947","volume":"134","author":"J Wang","year":"2025","unstructured":"Wang J, Zhou L, Pan Y, Li C, Huang S, Yan Z, et al. USP7-DDX5-FASN axis drives fatty acid metabolism and supports hepatocellular carcinoma progression. Cell Signal. 2025a;134:111947.","journal-title":"Cell Signal"},{"issue":"6","key":"10192_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05747-7","volume":"14","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Xiao L, Zhou L. Usp8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization. Cell Death Dis. 2023a;14(6):360.","journal-title":"Cell Death Dis"},{"key":"10192_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115925","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhou D, Yao Y, Sun Y, Yao F, Ma L. Monoubiquitination in homeostasis and cancer. Int J Mol Sci. 2022a. https:\/\/doi.org\/10.3390\/ijms23115925.","journal-title":"Int J Mol Sci"},{"issue":"28","key":"10192_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads5467","volume":"11","author":"SR Gandu","year":"2025","unstructured":"Gandu SR, Rodriguez AR, Lamp J, Patel MV, Madura K, Vega IE, et al. Cypin regulates K63-linked polyubiquitination to shape synaptic content. Sci Adv. 2025;11(28):eads5467.","journal-title":"Sci Adv"},{"issue":"7","key":"10192_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073480","volume":"23","author":"NE Pellegrino","year":"2022","unstructured":"Pellegrino NE, Guven A, Gray K, Shah P, Kasture G, Nastke M-D, et al. The next frontier: translational development of ubiquitination, SUMOylation, and NEDDylation in cancer. Int J Mol Sci. 2022;23(7):3480.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10192_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/genes14040886","volume":"14","author":"Y Min","year":"2023","unstructured":"Min Y, Park H-B, Baek K-H, Hwang S. Cellular functions of deubiquitinating enzymes in ovarian adenocarcinoma. Genes. 2023;14(4):886.","journal-title":"Genes"},{"issue":"3","key":"10192_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101311","volume":"12","author":"Q Guo","year":"2025","unstructured":"Guo Q, Qin H, Chen Z, Zhang W, Zheng L, Qin T. Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality. Genes Dis. 2025;12(3):101311.","journal-title":"Genes Dis"},{"issue":"1","key":"10192_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.str.2019.10.008","volume":"28","author":"AJ Boughton","year":"2020","unstructured":"Boughton AJ, Krueger S, Fushman D. Branching via K11 and K48 bestows ubiquitin chains with a unique interdomain interface and enhanced affinity for proteasomal subunit Rpn1. Structure. 2020;28(1):29-43.e26.","journal-title":"Structure"},{"issue":"12","key":"10192_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ni.3258","volume":"16","author":"M Yang","year":"2015","unstructured":"Yang M, Chen T, Li X, Yu Z, Tang S, Wang C, et al. K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation. Nat Immunol. 2015;16(12):1253\u201362.","journal-title":"Nat Immunol"},{"issue":"2","key":"10192_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.celrep.2014.12.021","volume":"10","author":"M Gatti","year":"2015","unstructured":"Gatti M, Pinato S, Maiolica A, Rocchio F, Prato MG, Aebersold R, et al. RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage. Cell Rep. 2015;10(2):226\u201338.","journal-title":"Cell Rep"},{"issue":"1","key":"10192_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s44318-024-00291-2","volume":"44","author":"TD Fischer","year":"2025","unstructured":"Fischer TD, Bunker EN, Zhu PP, Le Guerrou\u00e9 F, Hadjian M, Dominguez-Martin E, et al. STING induces HOIP-mediated synthesis of M1 ubiquitin chains to stimulate NF-\u03baB signaling. Embo j. 2025;44(1):141\u201365.","journal-title":"Embo j"},{"key":"10192_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112798","author":"E Chakraborty","year":"2022","unstructured":"Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC). Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14112798.","journal-title":"Cancers (Basel)"},{"issue":"10504","key":"10192_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, et al. The Lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406(10504):731\u201378.","journal-title":"Lancet"},{"issue":"3","key":"10192_CR21","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10192_CR22","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"10192_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"10192_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03572-0","author":"H Chen","year":"2025","unstructured":"Chen H, Zhou Y, Zhang Y, Fan Y, Zheng L, Guo Q. TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression. Oncogene. 2025. https:\/\/doi.org\/10.1038\/s41388-025-03572-0.","journal-title":"Oncogene"},{"issue":"1","key":"10192_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06592-2","volume":"23","author":"J Zhao","year":"2025","unstructured":"Zhao J, Li Y, Zhu J, Li H, Jin X. Ubiquitination in hepatocellular carcinoma immunity. J Transl Med. 2025;23(1):574.","journal-title":"J Transl Med"},{"issue":"4","key":"10192_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03666-z","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng L, Chen M, Li Y, Li M, Hu S, Zhou B, et al. Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis. Cell Death Dis. 2021;12(4):405.","journal-title":"Cell Death Dis"},{"key":"10192_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.625169","author":"T Wan","year":"2021","unstructured":"Wan T, Lei Z, Tu B, Wang T, Wang J, Huang F. NEDD4 induces K48-linked degradative ubiquitination of hepatitis B virus X protein and inhibits HBV-associated HCC progression. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.625169.","journal-title":"Front Oncol"},{"issue":"1","key":"10192_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01927-2","volume":"10","author":"S-L Zhang","year":"2024","unstructured":"Zhang S-L, Zhang S-J, Li L, Zhang Y-W, Wang Z, Wang L, et al. NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression. Cell Death Discov. 2024a;10(1):154.","journal-title":"Cell Death Discov"},{"issue":"3","key":"10192_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","volume":"47","author":"L Peng","year":"2024","unstructured":"Peng L, Wu T, Liu Y, Zhao D, He W, Yuan Y. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cell Oncol. 2024;47(3):987\u20131004.","journal-title":"Cell Oncol"},{"key":"10192_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849625","author":"S Zhu","year":"2022","unstructured":"Zhu S, Gu H, Peng C, Xia F, Cao H, Cui H. Regulation of glucose, fatty acid and amino acid metabolism by ubiquitination and SUMOylation for cancer progression. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.849625.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10192_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1563","volume":"14","author":"C Su","year":"2024","unstructured":"Su C, Zhang H, Mo J, Liao Z, Zhang B, Zhu P. SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. Clin Transl Med. 2024;14(1):e1563.","journal-title":"Clin Transl Med"},{"key":"10192_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110994","volume":"114","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wei T, Guo D. The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cell Signal. 2024b;114:110994.","journal-title":"Cell Signal"},{"key":"10192_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483721","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Li Q, Tang Q, Shi G, Wu G, Mao X, et al. Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma. Front Immunol. 2024a;15:1483721.","journal-title":"Front Immunol"},{"key":"10192_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.920287","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Guo J, Wang Y, Ma Q, Shi Y, Cheng F, et al. Research progress of DUB enzyme in hepatocellular carcinoma. Front Oncol. 2022;12:920287.","journal-title":"Front Oncol"},{"key":"10192_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095005","author":"N Koo","year":"2022","unstructured":"Koo N, Sharma AK, Narayan S. Therapeutics targeting p53-MDM2 interaction to induce cancer cell death. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23095005.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10192_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14(1):6269.","journal-title":"Nat Commun"},{"issue":"24","key":"10192_CR37","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1158\/0008-5472.CAN-14-1446","volume":"74","author":"X Meng","year":"2014","unstructured":"Meng X, Franklin DA, Dong J, Zhang Y. MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74(24):7161\u20137.","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"10192_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10495-022-01728-x","volume":"27","author":"W Ke","year":"2022","unstructured":"Ke W, Zhang L, Zhao X, Lu Z. P53 m(6)A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis. Apoptosis. 2022;27(5\u20136):426\u201340.","journal-title":"Apoptosis"},{"issue":"7","key":"10192_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071879","volume":"11","author":"KI Pellot Ortiz","year":"2023","unstructured":"Pellot Ortiz KI, Rechberger JS, Nonnenbroich LF, Daniels DJ, Sarkaria JN. MDM2 inhibition in the treatment of glioblastoma: from concept to clinical investigation. Biomedicines. 2023;11(7):1879.","journal-title":"Biomedicines"},{"key":"10192_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026211","author":"AR Wasylishen","year":"2016","unstructured":"Wasylishen AR, Lozano G. Attenuating the p53 pathway in human cancers: many means to the same end. Cold Spring Harb Perspect Med. 2016. https:\/\/doi.org\/10.1101\/cshperspect.a026211.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"24","key":"10192_CR41","doi-asserted-by":"publisher","first-page":"18407","DOI":"10.1074\/jbc.M109.059568","volume":"285","author":"H Xu","year":"2010","unstructured":"Xu H, Zhang Z, Li M, Zhang R. MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change. J Biol Chem. 2010;285(24):18407\u201314.","journal-title":"J Biol Chem"},{"issue":"30","key":"10192_CR42","doi-asserted-by":"publisher","first-page":"22818","DOI":"10.1074\/jbc.M110.126920","volume":"285","author":"J Nie","year":"2010","unstructured":"Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y, et al. Smad ubiquitylation regulatory factor 1\/2 (Smurf1\/2) promotes p53 degradation by stabilizing the E3 ligase MDM2. J Biol Chem. 2010;285(30):22818\u201330.","journal-title":"J Biol Chem"},{"issue":"9","key":"10192_CR43","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.18632\/oncotarget.640","volume":"3","author":"Z Wang","year":"2012","unstructured":"Wang Z, Inuzuka H, Zhong J, Fukushima H, Wan L, Liu P, et al. DNA damage-induced activation of ATM promotes \u03b2-TRCP-mediated Mdm2 ubiquitination and destruction. Oncotarget. 2012;3(9):1026\u201335.","journal-title":"Oncotarget"},{"issue":"1","key":"10192_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21258-5","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Blayney A, Liu X, Gandy L, Jin W, Yan L, et al. EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction. Nat Commun. 2021;12(1):986.","journal-title":"Nat Commun"},{"issue":"3","key":"10192_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","volume":"140","author":"J Yuan","year":"2010","unstructured":"Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010;140(3):384\u201396.","journal-title":"Cell"},{"issue":"24","key":"10192_CR46","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/emboj.2011.419","volume":"30","author":"AK Hock","year":"2011","unstructured":"Hock AK, Vigneron AM, Carter S, Ludwig RL, Vousden KH. Regulation of p53 stability and function by the deubiquitinating enzyme USP42. EMBO J. 2011;30(24):4921\u201330.","journal-title":"EMBO J"},{"issue":"20","key":"10192_CR47","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10(20):9332\u201347.","journal-title":"Theranostics"},{"issue":"9","key":"10192_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107672","volume":"300","author":"K Tang","year":"2024","unstructured":"Tang K, Yin T, Deng B, Wang M, Ren Z, Wang S, et al. USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion. J Biol Chem. 2024;300(9):107672.","journal-title":"J Biol Chem"},{"issue":"3","key":"10192_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.7150\/ijbs.68179","volume":"18","author":"S Bian","year":"2022","unstructured":"Bian S, Ni W, Zhu M, Zhang X, Qiang Y, Zhang J, et al. Flap endonuclease 1 facilitated hepatocellular carcinoma progression by enhancing USP7\/MDM2-mediated P53 inactivation. Int J Biol Sci. 2022;18(3):1022\u201338.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10192_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2016.01.021","volume":"470","author":"G Lee","year":"2016","unstructured":"Lee G, Oh TI, Um KB, Yoon H, Son J, Kim BM, et al. Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells. Biochem Biophys Res Commun. 2016;470(1):181\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10192_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.119908","volume":"1872","author":"G Saha","year":"2025","unstructured":"Saha G, Ghosh MK. The key vulnerabilities and therapeutic opportunities in the USP7-p53\/MDM2 axis in cancer. Biochim Biophys Acta Mol Cell Res. 2025;1872(3):119908.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10192_CR52","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41467-019-09358-9","volume":"10","author":"KR Simonetta","year":"2019","unstructured":"Simonetta KR, Taygerly J, Boyle K, Basham SE, Padovani C, Lou Y, et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat Commun. 2019;10(1):1402.","journal-title":"Nat Commun"},{"issue":"1","key":"10192_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158(1):157\u201370.","journal-title":"Cell"},{"issue":"1","key":"10192_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"issue":"23","key":"10192_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6105","volume":"6","author":"P Sarode","year":"2020","unstructured":"Sarode P, Zheng X, Giotopoulou GA, Weigert A, Kuenne C, G\u00fcnther S, et al. Reprogramming of tumor-associated macrophages by targeting \u03b2-catenin\/FOSL2\/ARID5A signaling: a potential treatment of lung cancer. Sci Adv. 2020;6(23):eaaz6105.","journal-title":"Sci Adv"},{"issue":"1","key":"10192_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41418-024-01328-z","volume":"32","author":"L Xu","year":"2025","unstructured":"Xu L, Liu Q, Liu H, Fan F, Li P, Yue S, et al. Disrupting CCDC137-mediated LZTS2 and \u03b2-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via \u03b2-catenin and AKT. Cell Death Differ. 2025;32(1):134\u201348.","journal-title":"Cell Death Differ"},{"issue":"1","key":"10192_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/HEP.0000000000000299","volume":"79","author":"J Luo","year":"2024","unstructured":"Luo J, Gong L, Yang Y, Zhang Y, Liu Q, Bai L, et al. Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC. Hepatology. 2024a;79(1):61\u201378.","journal-title":"Hepatology"},{"issue":"13","key":"10192_CR58","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16(13):3797\u2013804.","journal-title":"EMBO J"},{"issue":"11","key":"10192_CR59","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1073\/pnas.96.11.6273","volume":"96","author":"C Liu","year":"1999","unstructured":"Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X. \u03b2-Trcp couples \u03b2-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci U S A. 1999;96(11):6273\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10192_CR60","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/jnci\/djh219","volume":"96","author":"A Ougolkov","year":"2004","unstructured":"Ougolkov A, Zhang B, Yamashita K, Bilim V, Mai M, Fuchs SY, et al. Associations among \u03b2-TrCP, an E3 ubiquitin ligase receptor, \u03b2-catenin, and NF-\u03baB in colorectal cancer. J Natl Cancer Inst. 2004;96(15):1161\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10192_CR61","doi-asserted-by":"publisher","first-page":"11221","DOI":"10.1074\/jbc.M611871200","volume":"282","author":"D Fang","year":"2007","unstructured":"Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, et al. Phosphorylation of & #x3b2;-Catenin by AKT Promotes & #x3b2;-Catenin Transcriptional Activity *. J Biol Chem. 2007;282(15):11221\u20139.","journal-title":"J Biol Chem"},{"issue":"8","key":"10192_CR62","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1128\/MCB.24.8.3404-3414.2004","volume":"24","author":"L L\u00e9vy","year":"2004","unstructured":"L\u00e9vy L, Wei Y, Labalette C, Wu Y, Renard C-A, Buendia MA, et al. Acetylation of \u03b2-catenin by p300 regulates \u03b2-catenin-Tcf4 interaction. Mol Cell Biol. 2004;24(8):3404\u201314.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10192_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1101\/gad.13.3.270","volume":"13","author":"JT Winston","year":"1999","unstructured":"Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999;13(3):270\u201383.","journal-title":"Genes Dev"},{"issue":"13","key":"10192_CR64","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022113033","volume":"42","author":"Y Cao","year":"2023","unstructured":"Cao Y, Zheng J, Wan H, Sun Y, Fu S, Liu S, et al. A mitochondrial SCF-FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease. EMBO J. 2023;42(13):e113033.","journal-title":"EMBO J"},{"issue":"12","key":"10192_CR65","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s13238-019-0652-x","volume":"10","author":"H Lan","year":"2019","unstructured":"Lan H, Sun Y. FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded. Protein Cell. 2019;10(12):861\u20133.","journal-title":"Protein Cell"},{"issue":"9","key":"10192_CR66","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1080\/15548627.2024.2353497","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y, Chen P, Wang S, Cai L, Zhu F, Jiang Y, et al. SCF(FBXW5)-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells. Autophagy. 2024;20(9):1984\u201399.","journal-title":"Autophagy"},{"issue":"12","key":"10192_CR67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309902121","volume":"121","author":"M Boretto","year":"2024","unstructured":"Boretto M, Geurts MH, Gandhi S, Ma Z, Staliarova N, Celotti M, et al. Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7. Proc Natl Acad Sci U S A. 2024;121(12):e2309902121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10192_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"CH Yeh","year":"2018","unstructured":"Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17(1):115.","journal-title":"Mol Cancer"},{"issue":"25","key":"10192_CR69","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/s41388-024-03048-7","volume":"43","author":"S Motomura","year":"2024","unstructured":"Motomura S, Yumimoto K, Tomonaga T, Nakayama KI. CRL2(KLHDC3) and CRL1(Fbxw7) cooperatively mediate c-Myc degradation. Oncogene. 2024;43(25):1917\u201329.","journal-title":"Oncogene"},{"issue":"1","key":"10192_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Luo L, Fu S, Wang M, Wang Z, Dong L, et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat Commun. 2023a;14(1):1011.","journal-title":"Nat Commun"},{"issue":"1","key":"10192_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"Luo L, Wu X, Fan J, Dong L, Wang M, Zeng Y, et al. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat Commun. 2024b;15(1):4790.","journal-title":"Nat Commun"},{"issue":"5","key":"10192_CR72","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/cas.13598","volume":"109","author":"H Jiang","year":"2018","unstructured":"Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, et al. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K\/Akt\/GSK-3\u03b2\/Snail signaling. Cancer Sci. 2018;109(5):1414\u201327.","journal-title":"Cancer Sci"},{"issue":"10","key":"10192_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1443","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xia P, Yang Z, Liu J, Zhu Y, Huang Z, et al. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box(FBXO11) -mediated heterogeneous nuclear ribonucleoprotein A2\/B1 ubiquitination and promote hepatocellular carcinoma. Clin Transl Med. 2023a;13(10):e1443.","journal-title":"Clin Transl Med"},{"issue":"7","key":"10192_CR74","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","volume":"30","author":"HH Liu","year":"2022","unstructured":"Liu HH, Xu Y, Li CJ, Hsu SJ, Lin XH, Zhang R, et al. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Mol Ther. 2022;30(7):2554\u201367.","journal-title":"Mol Ther"},{"issue":"5","key":"10192_CR75","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/HEP.0000000000000455","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology (Baltimore, MD). 2023;78(5):1602\u201324.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"10192_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2278-6","volume":"11","author":"Y Feng","year":"2020","unstructured":"Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, et al. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Cell Death Dis. 2020;11(2):89.","journal-title":"Cell Death Dis"},{"issue":"19","key":"10192_CR77","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.7150\/thno.44873","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen D, Wang Y, Lu R, Jiang X, Chen X, Meng N, et al. E3 ligase ZFP91 inhibits hepatocellular carcinoma metabolism reprogramming by regulating PKM splicing. Theranostics. 2020;10(19):8558\u201372.","journal-title":"Theranostics"},{"issue":"1","key":"10192_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42170-0","volume":"14","author":"DW Jeong","year":"2023","unstructured":"Jeong DW, Park JW, Kim KS, Kim J, Huh J, Seo J, et al. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat Commun. 2023;14(1):6370.","journal-title":"Nat Commun"},{"issue":"2","key":"10192_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.201402104","volume":"205","author":"LA Kane","year":"2014","unstructured":"Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol. 2014;205(2):143\u201353.","journal-title":"J Cell Biol"},{"issue":"1","key":"10192_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"PMJ Quinn","year":"2020","unstructured":"Quinn PMJ, Moreira PI, Ambr\u00f3sio AF, Alves CH. PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun. 2020;8(1):189.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10192_CR81","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, et al. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 2022;18(8):1879\u201397.","journal-title":"Autophagy"},{"issue":"1","key":"10192_CR82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/15548627.2024.2392415","volume":"21","author":"Z Xiong","year":"2025","unstructured":"Xiong Z, Yang L, Zhang C, Huang W, Zhong W, Yi J, et al. MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation. Autophagy. 2025;21(1):80\u2013101.","journal-title":"Autophagy"},{"key":"10192_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176057","volume":"959","author":"TY Zhou","year":"2023","unstructured":"Zhou TY, Ma RX, Li J, Zou B, Yang H, Ma RY, et al. Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer\u2019s disease. Eur J Pharmacol. 2023;959:176057.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10192_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron. 2015;85(2):257\u201373.","journal-title":"Neuron"},{"issue":"1","key":"10192_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10192_CR86","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301755R","volume":"38","author":"L Huang","year":"2024","unstructured":"Huang L, Che Z, Liu F, Ge M, Wu Z, Wu L, et al. ASB3 promotes hepatocellular carcinoma progression by mediating DR5 ubiquitination in TRAIL resistance. FASEB J. 2024;38(4):e23475.","journal-title":"FASEB J"},{"issue":"3","key":"10192_CR87","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jcmgh.2021.04.016","volume":"12","author":"S Xia","year":"2021","unstructured":"Xia S, Ji L, Tao L, Pan Y, Lin Z, Wan Z, et al. TAK1 is a novel target in hepatocellular carcinoma and contributes to sorafenib resistance. Cell Mol Gastroenterol Hepatol. 2021;12(3):1121\u201343.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10192_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061058","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Yu C, Zhang Q. Ubiquitin-proteasome system-regulated protein degradation in spermatogenesis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11061058.","journal-title":"Cells"},{"issue":"1","key":"10192_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02805-y","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, et al. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. J Exp Clin Cancer Res. 2023;42(1):225.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10192_CR90","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/15384101.2018.1456293","volume":"17","author":"O Tavana","year":"2018","unstructured":"Tavana O, Sun H, Gu W. Targeting HAUSP in both p53 wildtype and p53-mutant tumors. Cell Cycle. 2018;17(7):823\u20138.","journal-title":"Cell Cycle"},{"issue":"7","key":"10192_CR91","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","volume":"69","author":"S Ling","year":"2020","unstructured":"Ling S, Shan Q, Zhan Q, Ye Q, Liu P, Xu S, et al. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1\u03b1\/USP22 positive feedback loop upon TP53 inactivation. Gut. 2020;69(7):1322\u201334.","journal-title":"Gut"},{"issue":"1","key":"10192_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01963-5","volume":"9","author":"Q Shan","year":"2024","unstructured":"Shan Q, Yin L, Zhan Q, Yu J, Pan S, Zhuo J, et al. The p-MYH9\/USP22\/HIF-1\u03b1 axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Signal Transduct Target Ther. 2024;9(1):249.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10192_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05699-y","volume":"14","author":"K Zeng","year":"2023","unstructured":"Zeng K, Xie W, Wang C, Wang S, Liu W, Su Y, et al. USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell Death Dis. 2023;14(3):194.","journal-title":"Cell Death Dis"},{"issue":"10","key":"10192_CR94","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1111\/cas.15509","volume":"113","author":"X Sun","year":"2022","unstructured":"Sun X, Cai M, Wu L, Zhen X, Chen Y, Peng J, et al. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma. Cancer Sci. 2022;113(10):3463\u201375.","journal-title":"Cancer Sci"},{"issue":"1","key":"10192_CR95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/1878-0261.12596","volume":"14","author":"T Yuan","year":"2020","unstructured":"Yuan T, Chen Z, Yan F, Qian M, Luo H, Ye S, et al. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein. Mol Oncol. 2020;14(1):197\u2013210.","journal-title":"Mol Oncol"},{"issue":"9","key":"10192_CR96","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.7150\/ijbs.96031","volume":"20","author":"MH Xu","year":"2024","unstructured":"Xu MH, Zheng YM, Liang BG, Xu WX, Cao J, Wang P, et al. Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1\/2 axis in hepatocellular carcinoma. Int J Biol Sci. 2024;20(9):3269\u201384.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10192_CR97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/mab.2012.0120","volume":"32","author":"JJ Park","year":"2013","unstructured":"Park JJ, Yun JH, Baek KH. Polyclonal and monoclonal antibodies specific for ubiquitin-specific protease 20. Monoclonal Antibod Immunodiagn Immunother. 2013;32(3):193\u20139.","journal-title":"Monoclonal Antibod Immunodiagn Immunother"},{"issue":"16","key":"10192_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci U S A. 2024a;121(16):e2315541121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"10192_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci. 2023b;10(33):e2302953.","journal-title":"Adv Sci"},{"key":"10192_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040634","author":"YS Chang","year":"2022","unstructured":"Chang YS, Su CW, Chen SC, Chen YY, Liang YJ, Wu JC. Upregulation of USP22 and ABCC1 during sorafenib treatment of hepatocellular carcinoma contribute to development of resistance. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11040634.","journal-title":"Cells"},{"key":"10192_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canlet.2021.07.044","volume":"518","author":"T Jing","year":"2021","unstructured":"Jing T, Wang B, Yang Z, Liu Y, Xu G, Xu X, et al. Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma. Cancer Lett. 2021;518:266\u201377.","journal-title":"Cancer Lett"},{"issue":"11","key":"10192_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05341-3","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Hu T, Shen Z, Zheng Y, Geng Q, Li L, et al. Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC. Cell Death Dis. 2022a;13(11):951.","journal-title":"Cell Death Dis"},{"issue":"6","key":"10192_CR103","first-page":"2392","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Nadolny C, Chen Q, Ali W, Hashmi SF, Deng R. Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma. Am J Cancer Res. 2023b;13(6):2392\u2013409.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"10192_CR104","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13402-020-00568-8","volume":"44","author":"B Xiong","year":"2021","unstructured":"Xiong B, Huang J, Liu Y, Zou M, Zhao Z, Gong J, et al. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A. Cell Oncol (Dordr). 2021;44(2):329\u201343.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"10192_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01310-5","volume":"24","author":"M Hu","year":"2024","unstructured":"Hu M, Dai C, Sun X, Chen Y, Xu N, Lin Z, et al. Ubiquitination-specific protease 7 enhances stemness of hepatocellular carcinoma by stabilizing basic transcription factor 3. Funct Integr Genomics. 2024;24(1):28.","journal-title":"Funct Integr Genomics"},{"key":"10192_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111585","volume":"127","author":"L Xie","year":"2025","unstructured":"Xie L, Song D, Ouyang Z, Ning Y, Liu X, Li L, et al. USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination. Cell Signal. 2025;127:111585.","journal-title":"Cell Signal"},{"issue":"1","key":"10192_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04118-9","volume":"79","author":"T Zou","year":"2022","unstructured":"Zou T, Wang Y, Dong L, Che T, Zhao H, Yan X, et al. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression. Cell Mol Life Sci. 2022;79(1):70.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10192_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00456-3","volume":"19","author":"Q Wu","year":"2024","unstructured":"Wu Q, Qiu Y, Guo J, Yuan Z, Yang Y, Zhu Q, et al. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1. Biol Direct. 2024;19(1):13.","journal-title":"Biol Direct"},{"issue":"1","key":"10192_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-020-00245-6","volume":"26","author":"M Tracz","year":"2021","unstructured":"Tracz M, Bialek W. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett. 2021;26(1):1.","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"10192_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110354","volume":"38","author":"YT Wang","year":"2022","unstructured":"Wang YT, Liu TY, Shen CH, Lin SY, Hung CC, Hsu LC, et al. K48\/K63-linked polyubiquitination of ATG9A by TRAF6 E3 ligase regulates oxidative stress-induced autophagy. Cell Rep. 2022b;38(8):110354.","journal-title":"Cell Rep"},{"issue":"1","key":"10192_CR111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41401-024-01363-z","volume":"46","author":"X Wang","year":"2025","unstructured":"Wang X, Xie X, Ni JY, Li JY, Sun XA, Xie HY, et al. Usp11 promotes renal tubular cell pyroptosis and fibrosis in UUO mice via inhibiting KLF4 ubiquitin degradation. Acta Pharmacol Sin. 2025b;46(1):159\u201370.","journal-title":"Acta Pharmacol Sin"},{"issue":"14","key":"10192_CR112","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1111\/jcmm.16709","volume":"25","author":"H Yang","year":"2021","unstructured":"Yang H, Park D, Ryu J, Park T. Usp11 degrades KLF4 via its deubiquitinase activity in liver diseases. J Cell Mol Med. 2021;25(14):6976\u201387.","journal-title":"J Cell Mol Med"},{"key":"10192_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.015","volume":"514","author":"L Qiao","year":"2021","unstructured":"Qiao L, Zhang Q, Sun Z, Liu Q, Wu Z, Hu W, et al. The E2F1\/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK\/mTOR pathway. Cancer Lett. 2021;514:63\u201378.","journal-title":"Cancer Lett"},{"issue":"2","key":"10192_CR114","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/fon.10.187","volume":"7","author":"R Massoumi","year":"2011","unstructured":"Massoumi R. CYLD: a deubiquitination enzyme with multiple roles in cancer. Future Oncology (London, England). 2011;7(2):285\u201397.","journal-title":"Future Oncology (London, England)"},{"issue":"6","key":"10192_CR115","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41590-020-0681-x","volume":"21","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee S, Kumar R, Tsakem Lenou E, Basrur V, Kontoyiannis DL, Ioakeimidis F, et al. Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation. Nat Immunol. 2020;21(6):626\u201335.","journal-title":"Nat Immunol"},{"issue":"7","key":"10192_CR116","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.ymthe.2021.10.028","volume":"30","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wang S, Li HL, Luo H, Wu X, Lu J, et al. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9\/CYLD\/NF-\u03baB axis. Molecul Ther\u202f: J Am Soc Gene Ther. 2022b;30(7):2568\u201383.","journal-title":"Molecul Ther : J Am Soc Gene Ther"},{"issue":"8045","key":"10192_CR117","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-024-08136-y","volume":"637","author":"A Bhardwaj","year":"2025","unstructured":"Bhardwaj A, Panepinto MC, Ueberheide B, Neel BG. A mechanism for hypoxia-induced inflammatory cell death in cancer. Nature. 2025;637(8045):470\u20137.","journal-title":"Nature"},{"issue":"6","key":"10192_CR118","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1084\/jem.20062694","volume":"204","author":"WW Reiley","year":"2007","unstructured":"Reiley WW, Jin W, Lee AJ, Wright A, Wu X, Tewalt EF, et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med. 2007;204(6):1475\u201385.","journal-title":"J Exp Med"},{"issue":"35","key":"10192_CR119","doi-asserted-by":"publisher","first-page":"36171","DOI":"10.1074\/jbc.M406638200","volume":"279","author":"H Jono","year":"2004","unstructured":"Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, et al. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem. 2004;279(35):36171\u20134.","journal-title":"J Biol Chem"},{"issue":"12","key":"10192_CR120","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1084\/jem.20031187","volume":"198","author":"A Regamey","year":"2003","unstructured":"Regamey A, Hohl D, Liu JW, Roger T, Kogerman P, Toftgard R, et al. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J Exp Med. 2003;198(12):1959\u201364.","journal-title":"J Exp Med"},{"issue":"20","key":"10192_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205194","volume":"20","author":"N Suenaga","year":"2019","unstructured":"Suenaga N, Kuramitsu M, Komure K, Kanemaru A, Takano K, Ozeki K, et al. Loss of tumor suppressor CYLD expression triggers Cisplatin resistance in oral squamous cell carcinoma. Int J Mol Sci. 2019;20(20):5194.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10192_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070339","volume":"8","author":"CC Lee","year":"2013","unstructured":"Lee CC, Carette JE, Brummelkamp TR, Ploegh HL. A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-\u03baB. PLoS One. 2013;8(7):e70339.","journal-title":"PLoS One"},{"key":"10192_CR123","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70025","author":"W Chang","year":"2025","unstructured":"Chang W, Feng K, Zhou P, Gong D, Wang K, Huang A, et al. SPOP suppresses hepatocellular carcinoma growth and metastasis by ubiquitination and proteasomal degradation of TRAF6. Cancer Sci. 2025. https:\/\/doi.org\/10.1111\/cas.70025.","journal-title":"Cancer Sci"},{"key":"10192_CR124","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-biophys-083012-130338","volume":"42","author":"J Napetschnig","year":"2013","unstructured":"Napetschnig J, Wu H. Molecular basis of NF-\u03baB signaling. Annu Rev Biophys. 2013;42:443\u201368.","journal-title":"Annu Rev Biophys"},{"key":"10192_CR125","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"10192_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0352-z","volume":"16","author":"JJ Li","year":"2016","unstructured":"Li JJ, Luo J, Lu JN, Liang XN, Luo YH, Liu YR, et al. Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study. Cancer Cell Int. 2016;16:76.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10192_CR127","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/hep.30801","volume":"71","author":"H Wu","year":"2020","unstructured":"Wu H, Yang TY, Li Y, Ye WL, Liu F, He XS, et al. Tumor necrosis factor receptor-associated factor 6 promotes hepatocarcinogenesis by interacting with histone deacetylase 3 to enhance c-Myc gene expression and protein stability. Hepatology (Baltimore, MD). 2020;71(1):148\u201363.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"10192_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Z Ning","year":"2022","unstructured":"Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, et al. USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in hepatocellular carcinoma. Nat Commun. 2022;13(1):2187.","journal-title":"Nat Commun"},{"issue":"1","key":"10192_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35469-x","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang L, You W, Xu J, Dai J, Hua D, et al. PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nat Commun. 2022;13(1):7677.","journal-title":"Nat Commun"},{"issue":"1","key":"10192_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00809-7","volume":"13","author":"M Minderman","year":"2023","unstructured":"Minderman M, Lantermans HC, Gr\u00fcneberg LJ, Cillessen S, Bende RJ, van Noesel CJM, et al. MALT1-dependent cleavage of CYLD promotes NF-\u03baB signaling and growth of aggressive B-cell receptor-dependent lymphomas. Blood Cancer J. 2023;13(1):37.","journal-title":"Blood Cancer J"},{"issue":"6","key":"10192_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202420977","volume":"64","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Dai Y, Teng X, Li J. Visualization and quantification of single-base m(6)A methylation. Angew Chem Int Ed Engl. 2025;64(6):e202420977.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"15","key":"10192_CR132","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1039\/D5CS00479A","volume":"54","author":"X Teng","year":"2025","unstructured":"Teng X, Zhang Q, Dai Y, Hou H, Li J. Chemical-assisted analysis of epigenetic modifications. Chem Soc Rev. 2025;54(15):7271\u2013303.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10192_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05593-7","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Lei Y, Zhang G, Li X, Yuan J, Li T, et al. USP39 stabilizes \u03b2-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression. Cell Death Dis. 2023b;14(1):63.","journal-title":"Cell Death Dis"},{"issue":"1","key":"10192_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39537-0","volume":"13","author":"D Zhu","year":"2023","unstructured":"Zhu D, Qi H, Zhu H. hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt\/beta-catenin signaling pathway. Sci Rep. 2023;13(1):12544.","journal-title":"Sci Rep"},{"issue":"24","key":"10192_CR135","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1016\/j.jmb.2017.10.026","volume":"429","author":"AV Hauenstein","year":"2017","unstructured":"Hauenstein AV, Xu G, Kabaleeswaran V, Wu H. Evidence for M1-linked polyubiquitin-mediated conformational change in NEMO. J Mol Biol. 2017;429(24):3793\u2013800.","journal-title":"J Mol Biol"},{"issue":"6","key":"10192_CR136","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jhep.2013.01.025","volume":"58","author":"ST Yang","year":"2013","unstructured":"Yang ST, Yen CJ, Lai CH, Lin YJ, Chang KC, Lee JC, et al. SUMOylated CPAP is required for IKK-mediated NF-\u03baB activation and enhances HBx-induced NF-\u03baB signaling in HCC. J Hepatol. 2013;58(6):1157\u201364.","journal-title":"J Hepatol"},{"key":"10192_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032652","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, J\u00fccker M. The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci. 2023a. https:\/\/doi.org\/10.3390\/ijms24032652.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10192_CR138","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2020e10390","volume":"54","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Ni Q, Qin L, Shi Y. Microrna-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K\/AKT\/mTOR signaling. Braz J Med Biol Res. 2021;54(9):e10390.","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"10192_CR139","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.trecan.2023.09.004","volume":"9","author":"O Sahay","year":"2023","unstructured":"Sahay O, Barik GK, Islam S. FBXW10: a male-biased E3 ligase in liver cancer. Trends Cancer. 2023;9(11):876\u20138.","journal-title":"Trends Cancer"},{"issue":"5","key":"10192_CR140","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/carcin\/bgz138","volume":"41","author":"YD Luo","year":"2020","unstructured":"Luo YD, Zhang J, Fang L, Zhu YY, You YM, Zhang CC, et al. FBXW10 promotes hepatocarcinogenesis in male patients and mice. Carcinogenesis. 2020;41(5):689\u201398.","journal-title":"Carcinogenesis"},{"issue":"1","key":"10192_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03070-8","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Qi X, Zeng Z, Wang L, Wang J, Zhang T, et al. CRISPR\/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Sci Rep. 2017;7(1):2796.","journal-title":"Sci Rep"},{"issue":"2","key":"10192_CR142","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.devcel.2020.06.025","volume":"54","author":"C Ibar","year":"2020","unstructured":"Ibar C, Irvine KD. Integration of hippo-YAP signaling with metabolism. Dev Cell. 2020;54(2):256\u201367.","journal-title":"Dev Cell"},{"key":"10192_CR143","doi-asserted-by":"publisher","DOI":"10.34133\/research.0673","volume":"8","author":"X Fang","year":"2025","unstructured":"Fang X, Liu H, Liu J, Du Y, Chi Z, Bian Y, et al. Isobutyrate confers resistance to inflammatory bowel disease through host-microbiota interactions in pigs. Research. 2025;8:0673.","journal-title":"Research"},{"issue":"6","key":"10192_CR144","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cell.2016.11.005","volume":"167","author":"T Moroishi","year":"2016","unstructured":"Moroishi T, Hayashi T, Pan WW, Fujita Y, Holt MV, Qin J, et al. The hippo pathway kinases LATS1\/2 suppress cancer immunity. Cell. 2016;167(6):1525-1539 e1517.","journal-title":"Cell"},{"issue":"16","key":"10192_CR145","doi-asserted-by":"publisher","first-page":"15311","DOI":"10.1007\/s00432-023-05272-2","volume":"149","author":"H Shi","year":"2023","unstructured":"Shi H, Zou Y, Zhong W, Li Z, Wang X, Yin Y, et al. Complex roles of Hippo-YAP\/TAZ signaling in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(16):15311\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"10192_CR146","first-page":"69","volume":"2","author":"V Valero 3rd","year":"2015","unstructured":"Valero V 3rd, Pawlik TM, Anders RA. Emerging role of Hpo signaling and YAP in hepatocellular carcinoma. J Hepatocell Carcinoma. 2015;2:69\u201378.","journal-title":"J Hepatocell Carcinoma"},{"key":"10192_CR147","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0235","volume":"6","author":"Y Hou","year":"2025","unstructured":"Hou Y, Zhong S, Zheng Z, Du J, Nie R, Shi Q, et al. Magnetic shaftless propeller millirobot with multimodal motion for small-scale fluidic manipulation. Cyborg Bionic Syst. 2025;6:0235.","journal-title":"Cyborg Bionic Syst"},{"key":"10192_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2435236","author":"J Mo","year":"2024","unstructured":"Mo J, Su C, Li P, Yang Z, Tao R, Liu Q, et al. CKAP4 in hepatocellular carcinoma: competitive RETREG1\/FAM134B binding, reticulophagy regulation, and cancer progression. Autophagy. 2024. https:\/\/doi.org\/10.1080\/15548627.2024.2435236.","journal-title":"Autophagy"},{"issue":"1","key":"10192_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49045-y","volume":"15","author":"M Lin","year":"2024","unstructured":"Lin M, Zheng X, Yan J, Huang F, Chen Y, Ding R, et al. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation. Nat Commun. 2024a;15(1):4995.","journal-title":"Nat Commun"},{"issue":"40","key":"10192_CR150","doi-asserted-by":"publisher","first-page":"27382","DOI":"10.1021\/jacs.4c06402","volume":"146","author":"X Teng","year":"2024","unstructured":"Teng X, Zhao X, Dai Y, Zhang X, Zhang Q, Wu Y, et al. ClickRNA-PROTAC for Tumor-Selective Protein Degradation and Targeted Cancer Therapy. J Am Chem Soc. 2024;146(40):27382\u201391.","journal-title":"J Am Chem Soc"},{"issue":"9","key":"10192_CR151","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41418-024-01342-1","volume":"31","author":"S Bian","year":"2024","unstructured":"Bian S, Ni W, Zhou L, Tong Y, Dai C, Zhao X, et al. Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization. Cell Death Differ. 2024;31(9):1202\u201318.","journal-title":"Cell Death Differ"},{"key":"10192_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216439","volume":"577","author":"Z Tian","year":"2023","unstructured":"Tian Z, Xu C, He W, Lin Z, Zhang W, Tao K, et al. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. Cancer Lett. 2023b;577:216439.","journal-title":"Cancer Lett"},{"issue":"1","key":"10192_CR153","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/ijo.2015.2981","volume":"47","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang J, Zhou L, Sun W, Zheng ZG, Lu P, et al. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. Int J Oncol. 2015;47(1):231\u201343.","journal-title":"Int J Oncol"},{"key":"10192_CR154","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001096","author":"XT Lin","year":"2024","unstructured":"Lin XT, Luo YD, Mao C, Gong Y, Hou Y, Zhang LD, et al. Integrated ubiquitomics characterization of hepatocellular carcinomas. Hepatology. 2024b. https:\/\/doi.org\/10.1097\/HEP.0000000000001096.","journal-title":"Hepatology"},{"issue":"2","key":"10192_CR155","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/aps.2014.106","volume":"36","author":"XL Shi","year":"2015","unstructured":"Shi XL, Yang J, Mao N, Wu JH, Ren LF, Yang Y, et al. Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation. Acta Pharmacol Sin. 2015;36(2):252\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10192_CR156","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1535-7163.MCT-10-0794","volume":"10","author":"KF Chen","year":"2011","unstructured":"Chen KF, Yu HC, Liu CY, Chen HJ, Chen YC, Hou DR, et al. Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A. Mol Cancer Ther. 2011;10(5):892\u2013901.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10192_CR157","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bcpt.13832","volume":"132","author":"Y Liao","year":"2023","unstructured":"Liao Y, Hu K, Liu W, Wang W, Qiu H, Pan S, et al. Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathway. Basic Clin Pharmacol Toxicol. 2023;132(4):297\u2013311.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10192_CR158","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1021\/acs.jmedchem.3c01468","volume":"67","author":"Q Chang","year":"2024","unstructured":"Chang Q, Li J, Deng Y, Zhou R, Wang B, Wang Y, et al. Discovery of novel PROTAC degraders of p300\/CBP as potential therapeutics for hepatocellular carcinoma. J Med Chem. 2024;67(4):2466\u201386.","journal-title":"J Med Chem"},{"key":"10192_CR159","doi-asserted-by":"crossref","unstructured":"Wang X, Zhao Y, Li X, Zhang Q, He J, Liu Y, Li M, Luo Z: Liposomal STAT3-Degrading PROTAC Prodrugs Promote Anti-Hepatocellular Carcinoma Immunity via Chemically Reprogramming Cancer Stem Cells. Nano Lett 2024.","DOI":"10.1021\/acs.nanolett.4c00201"},{"key":"10192_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202505669","author":"X Li","year":"2025","unstructured":"Li X, Ouyang Z, Hetjens L, Ni M, Lin K, Hu Y, et al. Functional dendrimer nanogels for DNA delivery and gene therapy of tumors. Angew Chem Int Ed Engl. 2025. https:\/\/doi.org\/10.1002\/anie.202505669.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10192_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01967-3","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu H, Han J, Lv Y, Zhao Z, Zheng S, Sun Y, et al. Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression. J Nanobiotechnology. 2023;21(1):208.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"10192_CR162","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/HEP.0000000000001096","volume":"82","author":"XT Lin","year":"2025","unstructured":"Lin XT, Luo YD, Mao C, Gong Y, Hou Y, Zhang LD, et al. Integrated ubiquitomics characterization of hepatocellular carcinomas. Hepatology. 2025;82(1):42\u201358.","journal-title":"Hepatology"},{"issue":"1","key":"10192_CR163","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, et al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79(1):109\u201325.","journal-title":"J Hepatol"},{"issue":"5","key":"10192_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010544","volume":"18","author":"Z Kong","year":"2022","unstructured":"Kong Z, Yin H, Wang F, Liu Z, Luan X, Sun L, et al. Pseudorabies virus tegument protein UL13 recruits RNF5 to inhibit STING-mediated antiviral immunity. PLoS Pathog. 2022;18(5):e1010544.","journal-title":"PLoS Pathog"},{"key":"10192_CR165","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0106","volume":"5","author":"Y Wang","year":"2024","unstructured":"Wang Y, Uesugi K, Nitta T, Hiratsuka Y, Morishima K. Contractile and tensile measurement of molecular artificial muscles for biohybrid robotics. Cyborg Bionic Syst. 2024c;5:0106.","journal-title":"Cyborg Bionic Syst"},{"issue":"4","key":"10192_CR166","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang HM, Yeh ETH. SUMO: from bench to bedside. Physiol Rev. 2020;100(4):1599\u2013619.","journal-title":"Physiol Rev"},{"key":"10192_CR167","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0026","volume":"4","author":"G Ji","year":"2023","unstructured":"Ji G, Gao Q, Zhang T, Cao L, Sun Z. A heuristically accelerated reinforcement learning-based neurosurgical path planner. Cyborg Bionic Syst. 2023;4:0026.","journal-title":"Cyborg Bionic Syst"},{"issue":"4","key":"10192_CR168","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41417-022-00464-3","volume":"30","author":"H Wang","year":"2023","unstructured":"Wang H, Yang L, Liu M, Luo J. Protein post-translational modifications in the regulation of cancer hallmarks. Cancer Gene Ther. 2023c;30(4):529\u201347.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10192_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01560-5","volume":"9","author":"X Cheng","year":"2023","unstructured":"Cheng X, Wang K, Zhao Y, Wang K. Research progress on post-translational modification of proteins and cardiovascular diseases. Cell Death Discov. 2023;9(1):275.","journal-title":"Cell Death Discov"},{"issue":"1","key":"10192_CR170","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15548627.2021.2021495","volume":"19","author":"M Shariq","year":"2023","unstructured":"Shariq M, Quadir N, Alam A, Zarin S, Sheikh JA, Sharma N, et al. The exploitation of host autophagy and ubiquitin machinery by Mycobacterium tuberculosis in shaping immune responses and host defense during infection. Autophagy. 2023;19(1):3\u201323.","journal-title":"Autophagy"},{"key":"10192_CR171","volume":"10","author":"S Xiang","year":"2025","unstructured":"Xiang S, Zhan H, Zhan J, Li X, Lin X, Sun W. Breaking hypoxic barrier: oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy. Int J Pharm X. 2025;10:100400.","journal-title":"Int J Pharm X"},{"key":"10192_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424752","volume":"15","author":"C Chen","year":"2024","unstructured":"Chen C, Chen Z, Zhou Z, Ye H, Xiong S, Hu W, et al. T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma. Front Immunol. 2024;15:1424752.","journal-title":"Front Immunol"},{"issue":"14","key":"10192_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306827","volume":"11","author":"K Li","year":"2024","unstructured":"Li K, Zhang J, Lyu H, Yang J, Wei W, Wang Y, et al. CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation. Adv Sci. 2024b;11(14):e2306827.","journal-title":"Adv Sci"},{"issue":"1","key":"10192_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00394-2","volume":"12","author":"XM Li","year":"2023","unstructured":"Li XM, Zhao ZY, Yu X, Xia QD, Zhou P, Wang SG, et al. Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy. Exp Hematol Oncol. 2023;12(1):34.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"10192_CR175","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbcan.2018.08.002","volume":"1870","author":"SC Chang","year":"2018","unstructured":"Chang SC, Ding JL. Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2018;1870(2):165\u201375.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10192_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2025.113015","volume":"272","author":"X Lai","year":"2025","unstructured":"Lai X, Lu T, Zhang F, Khan A, Zhao Y, Li X, et al. Lysosome-targeted theranostics: integration of real-time fluorescence imaging and controlled drug delivery via Zn(II)-Schiff base complexes. J Inorg Biochem. 2025;272:113015.","journal-title":"J Inorg Biochem"},{"key":"10192_CR177","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0005","volume":"4","author":"K Qian","year":"2023","unstructured":"Qian K, Hu B, Yamamoto Y, Schuller BW. The voice of the body: why AI should listen to it and an archive. Cyborg Bionic Syst. 2023;4:0005.","journal-title":"Cyborg Bionic Syst"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10192-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:33:16Z","timestamp":1783009996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10192-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10192"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10192-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"83"}}